An individually-randomized, double-blind, placebo-controlled phase 2b trial (OEV-128) examining the efficacy of oral inactivated ETVAX vaccine to prevent enterotoxigenic E. coli-associated diarrhoea in Gambian children ages 6 to 18 months.
Latest Information Update: 30 Nov 2020
At a glance
- Drugs Traveller's diarrhoea vaccine (Primary)
- Indications Traveller's diarrhoea
- Focus Adverse reactions; Therapeutic Use
- Sponsors Scandinavian Biopharma
- 30 Nov 2020 New trial record